Physician
Nephrology
Dr. Katherine R. Tuttle, MD
|
|
Give Review
Katherine Tuttle practices Nephrology. He attended Northwestern University Feinberg School of Medicine. Northwestern University Feinberg School of Medicine is ranked 19/29 in Research/PrimaryCare. He received awards:"Fellow (ASNF)". Katherine Tuttle is a published physician as well. He has 84 publications published. The latest was: Endovascular stents for renal artery revascularization.
Publications
- The Surging Tide of Diabetes: Implications for Nephrology.
- Effect of Ruboxistaurin on Albuminuria and Estimated GFR in People With Diabetic Peripheral Neuropathy: Results From a Randomized Trial.
- Serum amyloid A and inflammation in diabetic Kidney disease and podocytes.
- Novel Therapies for Diabetic Kidney Disease.
- Observational Study of Kidney Function and Albuminuria in Patients With Type 2 Diabetes Treated With Exenatide BID Versus Insulin Glargine.
- New Therapies for Diabetic Kidney Disease.
- Effects of Exenatide on Kidney Function, Adverse Events, and Clinical End Points of Kidney Disease in Type 2 Diabetes.
- Type 2 Translational Research for CKD.
- Direct and Indirect Effects of Obesity on the Kidney.
- Kidney disease and increased mortality risk in type 2 diabetes.
- Glomerular cell death and inflammation with high-protein diet and Diabetes.
- Classification of Chronic Kidney Disease Biomarkers to Predict Coronary Artery Calcium.
- Co-occurring mood Disorders among hospitalized patients and risk for subsequent medical hospitalization.
- Dietary amino acids and blood pressure: a cohort study of patients With cardiovascular disease.
- Handbook of Chronic kidney disease management.
- Meta-analysis comparing mediterranean to low-fat diets for modification of cardiovascular risk factors.
- Modulation of advanced glycation end products by candesartan in patients with diabetic Kidney disease--a dose-response relationship study.
- Charting new territory by simulated modeling of a clinical trial.
- Prevention of diabetic Kidney disease: negative clinical trials with renin-angiotensin system inhibitors.
- Management of the diabetic patient with advanced Chronic kidney disease.
- Longitudinal relationships among coronary artery calcification, serum phosphorus, and Kidney function.
- Should albuminuria be a focus of antiHypertensive therapy goals?
- Can comprehensive lifestyle change alter the course of Chronic kidney disease?
- The "Eco-Atkins" diet: new twist on an old tale.
- Obesity management in adults With CKD.
- More is not always better: intensive glycemic control in type 2 Diabetes.
- Comparison of low-fat versus Mediterranean-style dietary intervention after first myocardial infarction (from The Heart Institute of Spokane Diet Intervention and Eval...
- Do agents that block the RAS truly offer renoprotective effects in early stage, nonproteinuric Nephropathy?
- Effect of ruboxistaurin on urinary transforming growth factor-beta in patients with diabetic nephropathy and type 2 Diabetes.
- Advanced glycation end products and nephrotoxicity of high-protein diets.
- Implications of Chronic kidney disease for dietary treatment in cardiovascular disease.
- NKF releases new KDOQI guidelines for Diabetes and CKD.
- A causal role for uric acid in fructose-induced metabolic syndrome.
- The effect of ruboxistaurin on nephropathy in type 2 Diabetes.
- Linking Metabolism and immunology: diabetic nephropathy is an inflammatory disease.
- The next generation of diabetic Nephropathy therapies: an update.
- Amino acids injure mesangial cells by advanced glycation end products, oxidative stress, and protein kinase C.
- Clinical evidence for the influence of uric acid on hypertension, cardiovascular disease, and Kidney disease: a statistical modeling perspective.
- Cardiovascular implications of albuminuria.
- Quiz page. Primary hyperparathyroidism.
- A novel potential therapy for diabetic Nephropathy and vascular complications: protein kinase C beta inhibition.
- Amino acids induce indicators of response to injury in glomerular mesangial cells.
- Is there a pathogenetic role for uric acid in hypertension and cardiovascular and Renal disease?
- Predictors of ARF after cardiac surgical procedures.
- Renal parenchymal injury as a determinant of clinical consequences in atherosclerotic Renal artery stenosis.
- Effects of amino acids and glucagon on renal hemodynamics in type 1 Diabetes.
- Effects of amino acids and glucose on mesangial cell aminopeptidase a and angiotensin receptors.
- Kidney outcomes in long-term studies of ruboxistaurin for diabetic eye disease.
- Atherosclerotic Renal artery stenosis: current status and future directions.
- Influence of glycemic control on the development of diabetic cardiovascular and Kidney disease.
- Elevations in serum creatinine with RAAS blockade: why isn''t it a sign of Kidney injury?
- Oxidative stress mediates protein kinase C activation and advanced glycation end product formation in a mesangial cell model of Diabetes and high protein diet.
- Could renin inhibition be the next step forward in the treatment of diabetic Kidney disease?
- Protein kinase C-beta inhibition for diabetic Kidney disease.
- Protein kinase C beta inhibition: the promise for treatment of diabetic Nephropathy.
- Uric acid, microalbuminuria and cardiovascular events in high-risk patients.
- Renal manifestations of the metabolic syndrome.
- Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome.
- The new KDOQI clinical practice guidelines and clinical practice recommendations for Diabetes and CKD.
- Diabetic nephropathy: implications for Renal and cardiovascular outcomes.
- Increased lipoprotein(a) concentrations in Chronic renal failure.
- Lack of change of lipoprotein (a) concentration with improved glycemic control in subjects with type II Diabetes.
- Effect of insulin therapy on renal hemodynamic response to amino acids and renal hypertrophy in non-insulin-dependent Diabetes.
- Treatment of diabetic Nephropathy: a rational approach based on its pathophysiology.
- Decrease of lipoprotein(a) With improved glycemic control in IDDM subjects.
- Altered renal Calcium handling in hypercalcemia of malignancy.
- Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent Diabetes mellitus.
- The natural history of diabetic Nephropathy.
- Glucagon, not insulin, may play a Secondary role in defense against hypoglycemia during exercise.
- Treatment of atherosclerotic ostial renal artery stenosis With the intravascular stent.
- Screening for Renal artery stenosis: hypertension and more...
- Endovascular stents for Renal artery revascularization.
- Urinary albumin and insulin as predictors of coronary artery Disease: An angiographic study.
- Much ado about nothing, or much to do about something? The continuing controversy over the role of uric acid in cardiovascular Disease.
- Toward more rational management of ischemic Nephropathy: the need for clinical evidence.
- Ischemic Nephropathy.
- Sex differences in uric acid and risk factors for coronary artery Disease.
- Albuminuria reduction: the holy grail for Kidney protection.
- Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration.
- Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Wor...
- Estramustine affects bone mineral Metabolism in metastatic prostate cancer.
- Association of co-occurring serious mental illness with emergency hospitalization in people with Chronic kidney disease.
- Urinary excretion of RAS, BMP, and WNT pathway components in diabetic Kidney disease.
Schools
Northwestern University The Feinberg School Of Medicine
Northwestern University
Northwester University
Washington University
University Tex
Conditions Treated
- Calcium Metabolism Disorders
- Chronic Kidney Diseases
- Diabetes With Renal Manifestations
- Gout
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- First Choice Health PPO
- First Health (Coventry Health Care) PPO
- Coop Core
- Connect
- MultiPlan PPO
- PHCS Network PPO
- ODS Health Plan
- Heritage Plus
- Heritage Signature
- Personal Option EPO
- Preferred Provider Network PPN
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- Fellow (ASNF)
Education
-
University of Texas Health Science Center -
McGaw Medical Center of Northwestern University -
Northwestern University Feinberg School of Medicine
Drug Facts
| NPI NUMBER | 1740399492 | |
| NPPES Provider LastName | TUTTLE | |
| NPPES Provider FirstName | KATHERINE | |
| NPPES Provider ZIPCode | 992042302 | |
| NPPES Provider State | WA | |
| Specialty Description | Nephrology | |
| Total Claim Count | 372.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1740399492 |
| Last Name Of The Provider | TUTTLE |
| First Name Of The Provider | KATHERINE |
| View All |
Similar Doctors
|
Dr. Nelson Chow, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samer H. Bani Hani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leo E. Obermiller Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Henry Mroch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sean I. Sanchez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Margaret W. King, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Vijayakumar K. Reddy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Vicki M. Hoerner, NP |